ArticleJournal of neuro-oncology2019

The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.

Brent Holmes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.